Alnylam Pharmaceuticals, Inc.
POLYNUCLEOTIDE AGENTS TARGETING HYDROXYACID OXIDASE (GLYCOLATE OXIDASE, HAO1) AND METHODS OF USE THEREOF

Last updated:

Abstract:

The invention relates to polynucleotide agents targeting an hydroxyacid oxidase (HAO1) gene, and methods of using such polynucleotide agents to inhibit expression of HAO1 and to treat subjects having an HAO1-associated disease, e.g., hyperoxaluria.

Status:
Application
Type:

Utility

Filling date:

3 Feb 2021

Issue date:

30 Dec 2021